Biogen Inc. (BIIB): EBITDA
Older than the company's other figures. The latest EBITDA is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Operating Income, which EBITDA is computed from, under the concepts TickerFacts maps.
$3.33B
Year ended 2021-12-31
-20.2%
3-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $3.33B | -33.5% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $5.01B | -33.3% | 2023-02-15, From 2020-01-01 |
| 2019-12-31 | $7.51B | +14.8% | 2022-02-03, From 2019-01-01 |
| 2018-12-31 | $6.54B | n/c | 2021-02-03, From 2018-01-01 |
| 2017-12-31 | $6.43B | +10.2% | 2020-02-06, From 2017-01-01 |
| 2016-12-31 | $5.83B | +6.2% | 2019-02-06, From 2016-01-01 |
| 2015-12-31 | $5.49B | +17.8% | 2018-02-01, From 2015-01-01 |
| 2014-12-31 | $4.66B | +52.9% | 2017-02-02, From 2014-01-01 |
| 2013-12-31 | $3.05B | +37.2% | 2016-02-03, From 2013-01-01 |
| 2012-12-31 | $2.22B | +6.6% | 2015-02-04, From 2012-01-01 |
| 2011-12-31 | $2.08B | +29.9% | 2014-02-06, From 2011-01-01 |
| 2010-12-31 | $1.60B | -6.9% | 2013-02-05, From 2010-01-01 |
| 2009-12-31 | $1.72B | +2.8% | 2012-02-03, From 2009-01-01 |
| 2008-12-31 | $1.68B | +44.4% | 2011-02-04, From 2008-01-01 |
| 2007-12-31 | $1.16B | n/a | 2010-02-09, From 2007-01-01 |